Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.0996
-0.0045 (-4.32%)
Oct 3, 2025, 2:33 PM EDT
Ayala Pharmaceuticals Market Cap
Ayala Pharmaceuticals has a market cap or net worth of $4.91 million as of October 6, 2025. Its market cap has decreased by -87.36% in one year.
Market Cap
4.91M
Enterprise Value
8.34M
Revenue
13.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since October 19, 2023, Ayala Pharmaceuticals's market cap has decreased from 9.68M to 4.91M, a decrease of -49.26%. That is a compound annual growth rate of -29.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 4.91M | 268.89% |
| Dec 31, 2024 | 1.33M | -83.23% |
| Dec 29, 2023 | 7.94M | -18.00% |
| Oct 19, 2023 | 9.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |